Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin in Children with ADHD and Sleep Problems
NCT04318067Phase 4Unknown
- Start
- Sep 2020
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of melatonin in sleep disorder. Primary endpoints: Sleep onset Latency at 6 months, Sleep onset at 6 months and 1 more. Status: unknown.
02
Drugs
melatonin
03
Conditions
sleep disorder
Beyond the preview
Go deeper on NCT04318067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04318067.